From The Source

CSL cracks bird flu vaccine markets in the EU and US

3 minute read

Members Pharma/Biotech Public Health

By

Staff Writers

More than 5 million doses of the H5N8 vaccine will be produced at manufacturing sites in Amsterdam, Liverpool and North Carolina.

More than 5 million doses of the H5N8 vaccine will be produced at manufacturing sites in Amsterdam, Liverpool and North Carolina.

This content is for Health Services Daily subscribers only.
or Join Now.

End of content

No more pages to load

Log In Register ×